Universal Health Services Reports Strong Q1 2026 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: PRnewswire
- Net Income Growth: In Q1 2026, Universal Health Services reported net income of $348.7 million, or $5.65 per diluted share, compared to $316.7 million and $4.80 per diluted share in Q1 2025, indicating a significant improvement in profitability and reflecting strong performance in the healthcare sector.
- Significant Revenue Increase: The net revenues for Q1 2026 reached $4.495 billion, a 9.6% increase year-over-year, demonstrating sustained demand in acute care and behavioral health services, which enhances the company's competitive position in the industry.
- Strong EBITDA Performance: The EBITDA for Q1 2026 was $651.7 million, up 9.5% from $603.9 million in Q1 2025, showcasing ongoing improvements in operational efficiency and cost control, further solidifying the company's financial health.
- Robust Cash Flow: The net cash provided by operating activities for Q1 2026 was $402 million, an increase of $42 million from $360 million in 2025, reflecting significant enhancements in cash management and operational efficiency, thereby strengthening the company's capacity for future investments and expansion.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UHS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UHS
Wall Street analysts forecast UHS stock price to rise
15 Analyst Rating
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 174.350
Low
190.00
Averages
248.00
High
302.00
Current: 174.350
Low
190.00
Averages
248.00
High
302.00
About UHS
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 359 inpatient facilities, and 60 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, physician recruitment services, and public relations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UHS to Announce Q1 Earnings on April 27
- Earnings Announcement: Universal Health Services (UHS) is set to release its Q1 2023 earnings report on April 27 after market close, with a consensus EPS estimate of $5.46, reflecting a 12.8% year-over-year increase, indicating ongoing improvement in profitability.
- Revenue Growth Expectations: The anticipated revenue for Q1 is $4.39 billion, representing a 7.1% year-over-year increase, which highlights the company's stable growth in the healthcare sector and rising market demand, potentially boosting investor confidence.
- Historical Performance: Over the past two years, UHS has beaten EPS estimates 88% of the time and revenue estimates 75% of the time, a strong performance record that may attract more investor interest and enhance its market valuation.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 5 upward revisions and 4 downward revisions, while revenue estimates have experienced 6 upward and 4 downward revisions, indicating analysts' confidence in UHS's future performance and adjustments in market expectations.
See More
Universal Health Services Q1 Earnings Exceed Expectations
- Earnings Beat: Universal Health Services reported a Q1 non-GAAP EPS of $5.62, surpassing expectations by $0.16, which underscores the company's robust profitability in the healthcare sector and strengthens its market position.
- Significant Revenue Growth: The company achieved Q1 revenue of $4.49 billion, reflecting a 9.5% year-over-year increase and exceeding market expectations by $100 million, indicating successful market share expansion amid rising healthcare demand.
- Attractive Valuation: With a price-to-earnings ratio of 8x compared to HCA's 16x, Universal Health Services presents a compelling investment opportunity that may attract value investors and potentially drive stock price appreciation.
- Acquisition Strategy: The acquisition of Talkspace signifies a strategic shift towards hybrid healthcare models, aiming to enhance customer experience and competitive positioning through the integration of digital health services.
See More
Universal Health Services Reports Strong Q1 2026 Financial Results
- Net Income Growth: In Q1 2026, Universal Health Services reported net income of $348.7 million, or $5.65 per diluted share, compared to $316.7 million and $4.80 per diluted share in Q1 2025, indicating a significant improvement in profitability and reflecting strong performance in the healthcare sector.
- Significant Revenue Increase: The net revenues for Q1 2026 reached $4.495 billion, a 9.6% increase year-over-year, demonstrating sustained demand in acute care and behavioral health services, which enhances the company's competitive position in the industry.
- Strong EBITDA Performance: The EBITDA for Q1 2026 was $651.7 million, up 9.5% from $603.9 million in Q1 2025, showcasing ongoing improvements in operational efficiency and cost control, further solidifying the company's financial health.
- Robust Cash Flow: The net cash provided by operating activities for Q1 2026 was $402 million, an increase of $42 million from $360 million in 2025, reflecting significant enhancements in cash management and operational efficiency, thereby strengthening the company's capacity for future investments and expansion.
See More
Indie Semiconductor and Universal Health Services See Active Options Trading
- Indie Semiconductor Options Activity: Indie Semiconductor Inc (Ticker: INDI) recorded an options trading volume of 26,435 contracts today, equivalent to approximately 2.6 million shares, representing 73.3% of its average daily trading volume of 3.6 million shares over the past month, indicating strong market interest in its future performance.
- High Volume Contracts: Notably, the $4 strike call option has seen significant activity with 10,356 contracts traded today, representing about 1.0 million underlying shares, reflecting bullish sentiment among investors regarding the stock's potential upside.
- Universal Health Services Options Dynamics: Universal Health Services, Inc. (Ticker: UHS) experienced an options trading volume of 4,091 contracts today, equivalent to approximately 409,100 shares, which is 71.7% of its average daily trading volume of 570,435 shares over the past month, showcasing ongoing market interest in its stock.
- Key Contract Analysis: The $180 strike call option for UHS has seen 1,089 contracts traded today, representing approximately 108,900 underlying shares, indicating investor confidence in the company's growth prospects, particularly against the backdrop of sustained demand in the healthcare sector.
See More
U.S. Stocks Near All-Time Highs as Investors Eye Tech Giants' Earnings
- Strong Market Performance: The S&P 500 and Nasdaq Composite indices reached new all-time highs in April, rising over 8% and 13% respectively, indicating robust market resilience despite ongoing geopolitical tensions and AI disruption concerns, reflecting investor confidence in tech stocks.
- Earnings Pressure on Tech Giants: Next week, five of the 'Magnificent Seven' companies will report earnings, with market expectations for them to demonstrate sufficient revenue growth to justify their high AI expenditures; Alphabet, Amazon, Meta, and Microsoft have all seen stock price increases of over 10% this month, highlighting the market's keen interest in their performance.
- Federal Reserve Meeting Impact: This is expected to be Jerome Powell's last meeting as chair, with the market widely anticipating that the Fed will keep interest rates unchanged, although rising oil prices could complicate future monetary policy, necessitating close attention to how this dynamic may affect the market.
- Cautious Investor Sentiment: As the traditional market adage 'Sell in May' approaches, investors remain wary of potential downside risks, particularly in light of poor software stock performance and rising oil prices, which could further dampen market sentiment.
See More
US Stocks Decline as Oil Prices Surge Amid Iran Tensions
- Market Decline: The S&P 500 Index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.76%, and the Nasdaq 100 Index decreased by 1.40%, reflecting investor concerns over geopolitical tensions, particularly the potential escalation of conflict between Iran and the US.
- Oil Price Surge: Crude oil prices rose over 3% to a four-week high as the market watches for Iran's response to a ceasefire deadline tonight, with failure to reach an agreement potentially leading to broader military conflict and impacting global energy supplies.
- Positive Economic Data: Despite the overall market downturn, February's non-defense capital goods new orders increased by 0.6% month-over-month, surpassing expectations of 0.5%, indicating resilience in US capital spending that could support future market stability.
- Bond Market Reaction: The 10-year Treasury note yield rose to 4.357% as rising oil prices boosted inflation expectations, while the market's diminished outlook for a Fed rate hike reflects investor caution regarding future economic policies.
See More
UHS to Announce Q1 Earnings on April 27
- Earnings Announcement: Universal Health Services (UHS) is set to release its Q1 2023 earnings report on April 27 after market close, with a consensus EPS estimate of $5.46, reflecting a 12.8% year-over-year increase, indicating ongoing improvement in profitability.
- Revenue Growth Expectations: The anticipated revenue for Q1 is $4.39 billion, representing a 7.1% year-over-year increase, which highlights the company's stable growth in the healthcare sector and rising market demand, potentially boosting investor confidence.
- Historical Performance: Over the past two years, UHS has beaten EPS estimates 88% of the time and revenue estimates 75% of the time, a strong performance record that may attract more investor interest and enhance its market valuation.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 5 upward revisions and 4 downward revisions, while revenue estimates have experienced 6 upward and 4 downward revisions, indicating analysts' confidence in UHS's future performance and adjustments in market expectations.
See More
Universal Health Services Q1 Earnings Exceed Expectations
- Earnings Beat: Universal Health Services reported a Q1 non-GAAP EPS of $5.62, surpassing expectations by $0.16, which underscores the company's robust profitability in the healthcare sector and strengthens its market position.
- Significant Revenue Growth: The company achieved Q1 revenue of $4.49 billion, reflecting a 9.5% year-over-year increase and exceeding market expectations by $100 million, indicating successful market share expansion amid rising healthcare demand.
- Attractive Valuation: With a price-to-earnings ratio of 8x compared to HCA's 16x, Universal Health Services presents a compelling investment opportunity that may attract value investors and potentially drive stock price appreciation.
- Acquisition Strategy: The acquisition of Talkspace signifies a strategic shift towards hybrid healthcare models, aiming to enhance customer experience and competitive positioning through the integration of digital health services.
See More
Universal Health Services Reports Strong Q1 2026 Financial Results
- Net Income Growth: In Q1 2026, Universal Health Services reported net income of $348.7 million, or $5.65 per diluted share, compared to $316.7 million and $4.80 per diluted share in Q1 2025, indicating a significant improvement in profitability and reflecting strong performance in the healthcare sector.
- Significant Revenue Increase: The net revenues for Q1 2026 reached $4.495 billion, a 9.6% increase year-over-year, demonstrating sustained demand in acute care and behavioral health services, which enhances the company's competitive position in the industry.
- Strong EBITDA Performance: The EBITDA for Q1 2026 was $651.7 million, up 9.5% from $603.9 million in Q1 2025, showcasing ongoing improvements in operational efficiency and cost control, further solidifying the company's financial health.
- Robust Cash Flow: The net cash provided by operating activities for Q1 2026 was $402 million, an increase of $42 million from $360 million in 2025, reflecting significant enhancements in cash management and operational efficiency, thereby strengthening the company's capacity for future investments and expansion.
See More
Indie Semiconductor and Universal Health Services See Active Options Trading
- Indie Semiconductor Options Activity: Indie Semiconductor Inc (Ticker: INDI) recorded an options trading volume of 26,435 contracts today, equivalent to approximately 2.6 million shares, representing 73.3% of its average daily trading volume of 3.6 million shares over the past month, indicating strong market interest in its future performance.
- High Volume Contracts: Notably, the $4 strike call option has seen significant activity with 10,356 contracts traded today, representing about 1.0 million underlying shares, reflecting bullish sentiment among investors regarding the stock's potential upside.
- Universal Health Services Options Dynamics: Universal Health Services, Inc. (Ticker: UHS) experienced an options trading volume of 4,091 contracts today, equivalent to approximately 409,100 shares, which is 71.7% of its average daily trading volume of 570,435 shares over the past month, showcasing ongoing market interest in its stock.
- Key Contract Analysis: The $180 strike call option for UHS has seen 1,089 contracts traded today, representing approximately 108,900 underlying shares, indicating investor confidence in the company's growth prospects, particularly against the backdrop of sustained demand in the healthcare sector.
See More
U.S. Stocks Near All-Time Highs as Investors Eye Tech Giants' Earnings
- Strong Market Performance: The S&P 500 and Nasdaq Composite indices reached new all-time highs in April, rising over 8% and 13% respectively, indicating robust market resilience despite ongoing geopolitical tensions and AI disruption concerns, reflecting investor confidence in tech stocks.
- Earnings Pressure on Tech Giants: Next week, five of the 'Magnificent Seven' companies will report earnings, with market expectations for them to demonstrate sufficient revenue growth to justify their high AI expenditures; Alphabet, Amazon, Meta, and Microsoft have all seen stock price increases of over 10% this month, highlighting the market's keen interest in their performance.
- Federal Reserve Meeting Impact: This is expected to be Jerome Powell's last meeting as chair, with the market widely anticipating that the Fed will keep interest rates unchanged, although rising oil prices could complicate future monetary policy, necessitating close attention to how this dynamic may affect the market.
- Cautious Investor Sentiment: As the traditional market adage 'Sell in May' approaches, investors remain wary of potential downside risks, particularly in light of poor software stock performance and rising oil prices, which could further dampen market sentiment.
See More
US Stocks Decline as Oil Prices Surge Amid Iran Tensions
- Market Decline: The S&P 500 Index fell by 0.90%, the Dow Jones Industrial Average dropped by 0.76%, and the Nasdaq 100 Index decreased by 1.40%, reflecting investor concerns over geopolitical tensions, particularly the potential escalation of conflict between Iran and the US.
- Oil Price Surge: Crude oil prices rose over 3% to a four-week high as the market watches for Iran's response to a ceasefire deadline tonight, with failure to reach an agreement potentially leading to broader military conflict and impacting global energy supplies.
- Positive Economic Data: Despite the overall market downturn, February's non-defense capital goods new orders increased by 0.6% month-over-month, surpassing expectations of 0.5%, indicating resilience in US capital spending that could support future market stability.
- Bond Market Reaction: The 10-year Treasury note yield rose to 4.357% as rising oil prices boosted inflation expectations, while the market's diminished outlook for a Fed rate hike reflects investor caution regarding future economic policies.
See More
